Melatonin as an adjuvant therapy in preterm infants with neonatal sepsis, randomized trial
Abstract Background Neonatal sepsis (NS) is a systemic uncontrolled inflammatory response to an infectious agent, resulting in oxidative stress. Melatonin antioxidant and free radical scavenger proved to be safe in neonates. We aimed to evaluate the efficacy and safety of melatonin as adjuvant thera...
Saved in:
Main Authors: | Zeinab A. El-Kabbany (Author), Ola G. El-Farghali (Author), Soha M. Khafagy (Author), Hebatallah A. Shaaban (Author), Heba H. A. Osman (Author), Mohamed H. Metwally (Author) |
---|---|
Format: | Book |
Published: |
SpringerOpen,
2020-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Role of Montelukast in modulation of response to sepsis in preterm infants: a randomized-controlled trial
by: Nouran El-Shehaby, et al.
Published: (2023) -
Own Mother's Milk Protects against Necrotizing Enterocolitis, Sepsis and Poor Outcome of Preterm Infants
by: Salma Z. El Houchi, et al.
Published: (2022) -
Melatonin Supplementation as Adjuvant Therapy for the Prevention of Bronchopulmonary Dysplasia in Neonates
by: Mohamed Shawky Elfarargy, et al.
Published: (2020) -
Lactic acid as an adjuvant marker in pregnancyassociated sepsis
by: R Agarwal, et al.
Published: (2018) -
Enteral L-Arginine and Glutamine Supplementation for Prevention of NEC in Preterm Neonates
by: M. S. El-Shimi, et al.
Published: (2015)